大麻素在口腔癌中的作用
Brigitte Cretu1, Alexandra Zamfir1, Sandica Bucurica2,3
1Department of Oral and Maxillofacial Surgery, "Carol Davila" Central Military Emergency Hospital, 010825 Bucharest, Romania.
International journal of molecular sciences
|January 23, 2024
概括
在体外,大麻素对口腔癌细胞表现出潜在的抗癌作用,包括抑制细胞亡和增殖. 然而,关于大麻使用和口腔癌风险的研究仍然存在矛盾,需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大麻素在各种疾病 (包括癌症) 中的潜在作用方面越来越受到关注.
- 越来越多地使用大麻素来管理与癌症相关的症状,需要了解它们对口腔癌的影响.
研究的目的:
- 审查关于大麻素和口腔癌之间的关系的当前发现.
- 探索将大麻素与口腔癌的发病机制联系在一起的分子机制.
- 概述在口腔癌管理中使用大麻素化合物的观点.
主要方法:
- 流行病学数据和体外研究的文献综述.
- 对实验模型的分析,研究大麻素对口腔癌细胞的影响.
- 检查已批准的大麻素作为医疗辅助剂的用途.
主要成果:
- 关于大麻使用和口腔癌的流行病学数据是相互矛盾的.
- 实验室内研究表明,大麻素具有抗癌特性,如诱导亡和抑制扩散.
- 大麻素可能会降低参与口腔癌进展的关键信号通路的调节.
结论:
- 大麻素和口腔癌之间的关系是复杂的,并未完全理解.
- 进一步的研究对于确定大麻素在口腔癌中的潜在风险或保护作用至关重要.
- 大麻素在治疗癌症相关症状和改善患者幸福感方面可能有好处.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
279
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
279
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


